We measured the levels of interferon alpha (IFNa) in the sera of Thai children hospitalized with dengue hemorrhagic fever (DHF) or dengue fever (DF) to examine the role of IFNa in dengue virus infections of humans. The percentage of patients who had detectable levels of IFNa ( 3 U/ml) was higher in patients with DHF (80%, P < 0.001) and in patients with DF (60%, P < 0.001) than in healthy Thai children (7%). The levels of IFNa were higher in patients with DHF and in patients with DF on the first few days after the onset of fever than in healthy Thai children. The average levels of IFNa in patients with DHF were high two days before defervescence, decreasing gradually until the day of defervescence. There was a subset of patients with DHF who had increasing levels of IFNa after defervescence. However, the levels of IFNa in patients with DF were not high after fever subsided. The levels of IFNa were not different among children with DHF grades 1, 2 and 3. Among patients with DHF, T lymphocytes were activated to a higher degree in high IFNa producers than in low IFNa producers. These results indicate that similarly
high levels of IFNa are produced in vivo during the acute stages of DHF and DF, and that high levels of IFNa remain after fever subsides in some patients with DHF, but not in patients with DF.
Dengue virus infections are a major cause of morbidity in tropical and subtropical areas of the world. Dengue virus infection causes two forms of illness; dengue fever (DF) and dengue hem orrhagic fever (DHF).' Dengue fever is a self limited febrile disease, while DHF is a severe, sometimes fatal syndrome characterized by hemorrhagic manifestations and plasma leakage that may lead to shock. The mechanisms of re covery from dengue virus infection and the pathogenesis of DHF are not clearly understood.
We have reported that dengue virusâ€"infected cells are lysed by natural killer cells and by an tibody-dependent cell-mediated cytotoxicity.2 We have also reported the presence of dengue virus specific, cytotoxic T lymphocytes that lyse den gue virus-infected cells in a major histocompat ibility complexâ€"restricted fashion.3'4 Antibodies to dengue viruses neutralize the virus and can prevent infection.5 These immune responses may be important in prevention and recovery from dengue virus infection, and may contribute to the pathogenesis of DHF. We have detected higher levels of activation of T lymphocytes in patients with DHF than in those with DF, and have hypothesized that dengue virus-specific T cells play an important role in the pathogenesis of DHF.6 Another host defense mechanism that should be considered is interferon (IFN) pro duction. It has been reported that IFN has an important role in controlling viral infections. 7 We have reported that dengue virusâ€"infected monocytes produce IFNa,8 and that dengue vi rus-infected monocytes also induced IFNa from autologous nonimmune lymphocytes.9 Interfer on alpha produced by these two mechanisms protects uninfected monocytes from dengue vi rus infection.8'9 In addition to antiviral effects, IFNa has immunoregulating effects on natural killer cells,'Â°T cells,â€• and B cells.'2 Thus, IFNa may have important regulatory roles in the pathogenesis of DHF.
In this study, we examined the levels of IFNa 
PATIENTS AND METHODS

Patients and normal control donors
We examined serial serum specimens from 45 children with an age range of5â€"l4years (35 chil dren with DHF and 10 children with DF) who were hospitalized with dengue virus infections during 1987 and 1988 in the hemorrhagic fever unit of the Bangkok Children's Hospital. These sera were obtained from a randomly selected group ofsequential patients whose sera were sub mitted for evaluation of suspected dengue virus infection. Specimens were collected for diagnos tic studies by nurses participating in the project within 24 hr of admission to the hospital and daily until discharge; a convalescent specimen was also collected from each child 7â€"10 days after hospital admission. A portion ofeach specimen was kept at â€" 70Â°C and was available for analysis.
To study healthy children (controls), we ex amined aliquots of single serum specimens from a random sample of healthy Thai children (n = 30, age range 6â€"11years) obtained in an earlier cross-sectional study of hepatitis antibody prev alence. These sera were stored at â€" 70Â°Cfrom the time of collection until assay.
A diagnosis of dengue hemorrhagic fever was assigned to children with dengue infection when the level of thrombocytopenia and signs of hem orrhage and plasma leakage met established cii teria.'3 Hospitalized patients were followed with frequent determinations of blood pressure and pulse. Measurements of hematocrit in blood ob tained by fingerprick were recorded at 3â€"4-hr intervals, according to vital signs. Physical find ings of plasma leakage (pleural effusion, ascites) and indications of circulatory collapse (cyanosis, cold extremities) were recorded in the clinical record. Whenever feasible, chest radiographs in cluding decubitus views were performed to doc ument the presence of pleural fluid. Hemorrhagic manifestations (positive tourniquet test result for capillary fragility, skin hemorrhages, epistaxis, and gingival, gastrointestinal, or urinary tract hemorrhage) were also recorded. Without knowl edge ofIFNa levels, three ofthe investigators (S. N., B. L. I., and A. N.) reviewed every record, Dengue virus infections were confirmed by the detection of antiviral 1gM or increasing titers of antiviral hemagglutination-inhibiting antibodies or by virus isolation from plasma, according to previously published @ Cases of dengue infection were categorized as secondary (dengue infection in a child previously infected with a heterologous flavivirus) or primary (no prior fla vivirus infection) according to the presence or absence of an anamnestic antiflavivirus antibody response.'4. Table 1 shows the age and sex dis tribution and serologic data of patients and con trol subjects.
Assayfor IFNa
The levels of IFNa were measured in sand wich-type enzyme-linked immunosorbent assays (ELISA) as previously described.'5â€•6 Fifty mi croliters of pwified monoclonal antibodies to hu Â±2.9(5â€"14) 9.9 Â±2.9 (5â€"14) 7.9Â±1.4(6-11)3 4 032 6 0DHF â€" denguehemorrhagicfever DF â€" dengue fever.
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washed four times with Tween 20-PBS. Horse radish peroxidaseâ€"linked calf antihuman IFNa 
Statistical analysis
Differences between values were examined us ing the Student's t-test and the chi-square test. The levels ofIFNa were log-transformed for sta tistical analysis. Undetectable levels ofIFNa (< 3 IU/ml) were considered to be 1 IU/ml for log transformation. Differences yielding P values of 0.05 were regarded as significant.
RESULTS
Levels of IFNa in the sera of patients with DHF or DF
The sera from patients with DHF or DF were examined for levels of IFNa. These levels were then compared with levels in the sera of healthy Thai children. The day of onset of fever was defined as day 0 (Figure 1) . Interferon alpha was detected in 80% (28 of 35) of the patients with DHF and in 60% (6 of 10) of the patients with DF during days 1â€"20 after the onset of fever, while only 7% (2 of 30) of the sera of healthy Thai children contained detectable levels ofIFNa (P < 0.001 for DHF and P < 0.001 for DF, by chi-square test) ( Figure 1 ).
The levels of IFNa in the sera of patients with acute DHF were higher than those in the sera of healthy Thai children (P < 0.001 on day 3 and P < 0.05 on days 2 and 4), and the levels were also high on days 6â€"20after onset of fever (P < 0.05 ondays6,P< 0.O2onday7,andP< IFNa did not change during days 0â€"19.The lev els of IFNa in patients with DF were high one day before and on the day of defervescence, but these levels were not high after the fever subsid ed.
Changes intheserum levels ofIFNa ineach patientwithDHF
We attempted to determine the changes in the levels of IFNa in each patient during the course of DHF. Patients with DHF were separated into two groups, based on the levels of IFNa on days 7â€"12 afterdefervescence: 11 subjects who had detectable levels of IFNa (> 3 lU/mi) ( Figure   3A ) and 10 patients who did not have detectable levels of IFNa ( Figure 3B ). Most of the patients who had detectable levels of IFNa on days 7â€"12 after defervescence had lower levels of IFNa dur 0.005 on days 10â€"20).The levels of IFNa in the sera of patients with acute DF were higher than those in the sera of healthy Thai children (P < 0.05 on day 1 and P < 0.005 on day 3); however, the levels were not high on days 4â€"20 after onset of fever ( Figure 1 ).
Levels of IFNa in the sera of patients before and after theday ofdefervescence
The timing of plasma leakage in patients with DHF is predictable; circulatory collapse occurs as fever subsides. Therefore, we evaluated the levels of IFNa in the patients with DHF or DF, defining the day ofdefervescence as day 0 ( Figure   2 ).The averagelevels of IFNa in patients with DHF were highest two days before deferves cence, and decreased gradually until the day of defervescence. However, the average levels of ing days 0-4 after defervescence ( Figure 3A) . Most of the patients who did not have detectable levels of IFNa during days 7â€"12 had detectable levels of IFNa during days 0-4 after defervescence (Fig  ure 3B ). It is of interest that high levels of IFNa were detected on days 7â€"19after defervescence in some patients who had lower levels of IFNa during the early stages of illness.
Comparison ofthelevels ofIFNa among patients withDHF grades1,2, and 3
The levels of IFNa were compared among pa tients with DHF grades 1, 2, and 3 from one day before defervescence to nine days after defer vescence (Figure 4 ). They did not differ among these three groups.
Levels of Tcell activation in high IFNa producers and low IFNa producers amongpatients with DHF
We have previously reported that T lympho cytes are highly activated in patients with DHF by determining the high serum levels of sIL-2R, sCD4, sCD8, IL-2, and IFN7.6 The levels of these soluble cell-surface proteins and lymphokines were compared between high IFNa producers and low IFNa producers among patients with DHF during days 2â€"8 after onset of fever (Table  2) . Patients who had serum IFNa levels higher than 30 IU/ml at least one day during days 2â€"8 after onset of fever were defined as high IFNa producers. Patients who did not have serum IFN levels higher than 10 IU/ml during this period were defined as low IFNa producers. ofslL-2R were significantly higher in high IFNa producers than in low IFNa producers (P < 0.001). The levels ofsCD4, IL-2, and IFN@y were higher in high IFNa producers than in low IFNa producers, but the differences were not statisti cally significant. These results suggest that T lym phocytes are activated to a higher degree in high IFNa producers than in low IFNa producers.
DISCUSSION
In this study, we examined the levels of IFNa in the sera ofpatients hospitalized with DHF or DF. The percentage of subjects who had detect able levels of IFNa and the levels of IFNa on days 1â€"3 after the onset of fever were higher in patients with DHF or DF than in healthy Thai children. These results indicate that high levels of IFNa are produced in vivo during the acute stage of dengue virus infection.
The average levels of IFNa in the sera of pa tients with DHF were also high on days 4â€"20 after the onset of fever, while the levels of IFNa in the sera of patients with DF were not high after day 4. The levels of IFNa in patients with DHF were high two days before defervescence and decreased gradually until the day of defer vescence, defined as day 0. The average levels of IFNa did not change between days 0 and 19.
Approximately half of the patients with DHF had detectable levels of IFNa on days 7â€"19 after defervescence, and the levels of IFNa were high er on days 7â€"19than on days 0â€"4 after defer vescence in these patients. In contrast, the av erage levels of IFNa in patients with DF were high one day before defervescence and on the TAaut 2
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Fiouxn 3. Changes in the levels ofinterferon alpha (IFNa) in each patient with dengue hemorrhagic fever during the course of illness. Each line represents the changes in thelevels ofIFNa in one patient. A, patients who had detectable levels of IFNa ( 3 lU/mi) in their sera on days 7â€"12 after defervescence. B, patients who did not have detectable levels of IFNa on days 7â€"12 after defervescence.
Patienta with DHF who had serum IFNa levels higher than 30 lU/mi at leaat one day during days 2â€"S after the onset of fever were defined aa high IFNa producers. Patients with DHF who did not have serum IFNa levels higher than 10 lU/mi during days 2â€"S were defined as low IFNa responders. The highest levels of soluble interleukin-2 receptor (sIL-2R), sCD4, sCD8, IL-2, and lFN@ during days 2-S after the onset of fever were compared between high IFNa producers and low IFNa producers by Student's i-test. The titers of IL-2 and IFN-y were log-transformed for analysis. 
Days Beforeor After Defervescence
FlouxE4. Levels ofinterferon alpha(IFNa)inpatients withdenguehemorrhagic fever grades 1,2,and 3.
Levels are shown as mean titers + SEM. Values in parentheses above the bars are the number of samples. however, other mechanisms of IFNa production cannot be ruled out. The finding that some pa tients with DHF had increasing levels of IFNa during convalescence may suggest that the in fection was not completely eradicated even 7â€" 19 days after defervescence. We did not find in creasing levels of IFNa after defervescence in patients with DF, which possibly indicates that the termination of virus replication is more rap idly achieved in DF. Burke and Morrili reported that high levels of IFNa were detected in the plasma and cerebro spinal fluids of patients with Japanese enceph alitis, and that there was a positive correlation between the levels of IFNa in cerebrospinal flu ids and in fatal outcome)8 They interpreted that the correlation between high IFNa levels and fatal outcome reflects a higher degree of virus replication in the brain. Our observation that similar levels of IFNa were detected in patients with DHF and in patients with DF atleast during the early stage of illness suggests that the degree ofinfection may be similarbetween patients with DHF and patients with DF whose symptoms are severe enough to require hospitalization. The pa tients with DF examined in this study were hos pitalized and they had more severe symptoms than many children with DF who usually do not need to be hospitalized. Therefore, the sera of nonhospitalized children with less severe DF need to be examined in a future study.
Among patients with DHF, the levels of sIL 2R, sCD4, IL-2, and IFN'y were higher in sub jects who had high serum levels of IFNa than in those who had low serum levels of IFNa, al though the differences were not statistically sig nificant for sCD4, IL-2, and IFN'y. These results suggest that the levels of T cell activation are higher in high IFNa producers than in low IFNa producers. This difference may reflect the differ ence in the levels of dengue virus infections; i.e., higher levels of dengue virus replication induce higher levels of IFNa and also induce higher lev els of T cell activation.
Although this study does not suggest a direct role of IFNa in the pathogenesis of DHF, it is possible that IFNa has an important role in the control ofdengue virus infections. Thus, the role ofIFNa in recovery from dengue virus infection is an important subject for further investigation.
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